AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33
FIRST-LINE FLUDARABINE TREATMENT OF SYMPTOMATIC CHRONIC LYMPHOPROLIFERATIVE DISEASES - CLINICAL-RESULTS AND MOLECULAR ANALYSIS OF MINIMAL RESIDUAL DISEASE
Authors: CLAVIO M MIGLINO M SPRIANO M PIETRASANTA D VALLEBELLA E CELESTI L CANEPA L PIERRI I CAVALIERE M BALLERINI F BELTRAMI G ROSSI E VIMERCATI R BRUNI R CONGIU M NATI S DAMASIO E SANTINI G GOBBI M
Citation: M. Clavio et al., FIRST-LINE FLUDARABINE TREATMENT OF SYMPTOMATIC CHRONIC LYMPHOPROLIFERATIVE DISEASES - CLINICAL-RESULTS AND MOLECULAR ANALYSIS OF MINIMAL RESIDUAL DISEASE, European journal of haematology, 61(3), 1998, pp. 197-203
TREATMENT OF HAIRY-CELL LEUKEMIA WITH 2-CHLORODEOXYADENOSINE VIA THE GROUP-C PROTOCOL MECHANISM OF THE NATIONAL-CANCER-INSTITUTE - A REPORTOF 979 PATIENTS
Authors: CHESON BD SORENSEN JM VENA DA MONTELLO MJ BARRET JA DAMASIO E TALLMAN M ANNINO L CONNERS J COIFFIER B LAURIA F
Citation: Bd. Cheson et al., TREATMENT OF HAIRY-CELL LEUKEMIA WITH 2-CHLORODEOXYADENOSINE VIA THE GROUP-C PROTOCOL MECHANISM OF THE NATIONAL-CANCER-INSTITUTE - A REPORTOF 979 PATIENTS, Journal of clinical oncology, 16(9), 1998, pp. 3007-3015
VACOP-B VERSUS VACOP-B PLUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADVANCED DIFFUSE NON-HODGKINS-LYMPHOMA - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL BY THE NON-HODGKINS-LYMPHOMA COOPERATIVE STUDY-GROUP
Authors: SANTINI G SALVAGNO L LEONI P CHISESI T DESOUZA C SERTOLI MR RUBAGOTTI A CONGIU AM CENTURIONI R OLIVIERI A TEDESCHI L VESPIGNANI M NATI S SORACCO M PORCELLINI A CONTU A GUARNACCIA C PESCOSTA N MAJOLINO I SPRIANO M VIMERCATI R ROSSI E ZAMBALDI G MANGONI L ENDRIZZI L SILENI VC MIGGIANO MC MARINO G DAMASIO E RIZZOLI V
Citation: G. Santini et al., VACOP-B VERSUS VACOP-B PLUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADVANCED DIFFUSE NON-HODGKINS-LYMPHOMA - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL BY THE NON-HODGKINS-LYMPHOMA COOPERATIVE STUDY-GROUP, Journal of clinical oncology, 16(8), 1998, pp. 2796-2802
HIGH-DOSE CYCLOPHOSPHAMIDE (HDCY) FOLLOWED BY AUTOGRAFTING CAN IMPROVE THE OUTCOME OF RELAPSED OR RESISTANT NON-HODGKINS-LYMPHOMAS WITH INVOLVED OR HYPOPLASTIC MARROW
Authors: SANTINI G DESOUZA CA CONGIU AM NATI S MARINO G VASSALO F SPRIANO M ROSSI E VIMERCATI R PIAGGIO G FIGARI O BENVENUTO F ABATE M DAMASIO E
Citation: G. Santini et al., HIGH-DOSE CYCLOPHOSPHAMIDE (HDCY) FOLLOWED BY AUTOGRAFTING CAN IMPROVE THE OUTCOME OF RELAPSED OR RESISTANT NON-HODGKINS-LYMPHOMAS WITH INVOLVED OR HYPOPLASTIC MARROW, Bone marrow transplantation, 21, 1998, pp. 609-609
FLUDARABINE, ARA-C AND ANTRACYCLINE - A SHORT, INTENSIVE AND TOLERABLE INDUCTION THERAPY OF DE-NOVO ACUTE MYELOID-LEUKEMIA
Authors: CLAVIO M CERRI R PIERRI I BALLEARI E GATTO S BELTRAMI G MASOUDI B CAVALIERE M RISSO M PIETRASANTA D QUINTINO S DAMASIO E GHIO R GOBBI M
Citation: M. Clavio et al., FLUDARABINE, ARA-C AND ANTRACYCLINE - A SHORT, INTENSIVE AND TOLERABLE INDUCTION THERAPY OF DE-NOVO ACUTE MYELOID-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 220-221
FLUDARABINE COMBINATIONS WITH ARA-C AND ANTRACYCLINE AS FIRST-LINE INDUCTION THERAPY OF SECONDARY AML
Authors: PIERRI I CLAVIO M GATTO S CERRI R CANEPA L GATTI AM BALLERINI F QUINTINO S MASOUDI B CAVALIERE M SPRIANO R GHIO R DAMASIO E GOBBI H
Citation: I. Pierri et al., FLUDARABINE COMBINATIONS WITH ARA-C AND ANTRACYCLINE AS FIRST-LINE INDUCTION THERAPY OF SECONDARY AML, British Journal of Haematology, 102(1), 1998, pp. 221-221
COST OF DE-NOVO ACUTE MYELOID-LEUKEMIA INDUCTION, THERAPY - COMPARISON BETWEEN EORTC-GIMEMA AML10 AND FLANG REGIMENS
Authors: GOBBI M CLAVIO M MASOUDI B QUINTINO S PIERRI I CERRI R CANEPA L MUNER P RAINERO S RISSO M CAVALIERE M BELTRAMI G DAMASIO E
Citation: M. Gobbi et al., COST OF DE-NOVO ACUTE MYELOID-LEUKEMIA INDUCTION, THERAPY - COMPARISON BETWEEN EORTC-GIMEMA AML10 AND FLANG REGIMENS, British Journal of Haematology, 102(1), 1998, pp. 227-227
FLUDARABINE IN COMBINATION IN THE TREATMENT OF ADVANCED LOW-GRADE LYMPHOPROLIPHERATIVE DISORDERS
Authors: SPRIANO R BRUNI M CLAVIO F BALLERINI M MIGLINO E ROSSI D PIERLUIGI R VIMERCATI S NATI M CONGIU G SANTINI M",GOBBI,"DAMASIO E
Citation: R. Spriano et al., FLUDARABINE IN COMBINATION IN THE TREATMENT OF ADVANCED LOW-GRADE LYMPHOPROLIPHERATIVE DISORDERS, British Journal of Haematology, 102(1), 1998, pp. 244-245
MOLECULAR STUDY OF COMPLETE REMISSION IN CHRONIC LYMPHOPROLIFERATIVE DISORDERS AFTER FIRST LINE FLUDARABINE THERAPY
Authors: MIGLINO M CANEPA L PALMISANO G CLAVIO M CELESTI L SPRIANO M PIERRI I VALLEBELLA E CARRARA P CAVALIERE M PIETRASANTA D BALLERINI F BELTRAMI G SANTINI G DAMASIO E GOBBI M
Citation: M. Miglino et al., MOLECULAR STUDY OF COMPLETE REMISSION IN CHRONIC LYMPHOPROLIFERATIVE DISORDERS AFTER FIRST LINE FLUDARABINE THERAPY, Experimental hematology, 25(8), 1997, pp. 623-623
THE ROLE OF FLUDARABINE COMBINATIONS IN DE-NOVO ACUTE MYELOID-LEUKEMIA THERAPY - ANALYSIS OF 50 PATIENTS
Authors: GOBBI M CLAVIO M MIGLINO M QUINTINO S CERRI R RISSO M PIETRASANTA D PIERRI I BALLERINI F CAVALIERE M BELTRAMI G VALLEBELLA E CELESTI L CANEPA L SPRIANO M DAMASIO E
Citation: M. Gobbi et al., THE ROLE OF FLUDARABINE COMBINATIONS IN DE-NOVO ACUTE MYELOID-LEUKEMIA THERAPY - ANALYSIS OF 50 PATIENTS, Blood, 90(10), 1997, pp. 3825-3825
ANAPLASTIC LARGE-CELL LYMPHOMA - A CLINICOPATHOLOGICAL STUDY OF 53 PATIENTS
Authors: CLAVIO M ROSSI E TRUINI M CARRARA P RAVETTI JL SPRIANO M VIMERCATI AR SANTINI G CANEPA L PIERRI I CELESTI L MIGLINO M CASTELLANETA A DAMASIO E GOBBI M
Citation: M. Clavio et al., ANAPLASTIC LARGE-CELL LYMPHOMA - A CLINICOPATHOLOGICAL STUDY OF 53 PATIENTS, Leukemia & lymphoma, 22(3-4), 1996, pp. 319-327
ACCURACY OF 133-XENON REGIONAL CEREBRAL BLOOD-FLOW AND QUANTITATIVE ELECTROENCEPHALOGRAPHY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: NOBILI F RODRIGUEZ G ARRIGO A STUBINSKI BM ROSSI E CERRI R DAMASIO E ROSADINI G MARMONT AA
Citation: F. Nobili et al., ACCURACY OF 133-XENON REGIONAL CEREBRAL BLOOD-FLOW AND QUANTITATIVE ELECTROENCEPHALOGRAPHY IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Lupus, 5(2), 1996, pp. 93-102
DSDNA-REACTIVE, NUCLEOHISTONE-REACTIVE AND DNASE-I-REACTIVE T-LYMPHOCYTES IN PATIENTS AFFECTED BY SYSTEMIC LUPUS-ERYTHEMATOSUS - CORRELATION WITH CLINICAL-DISEASE ACTIVITY
Authors: FILACI G GRASSO I CONTINI P IMRO MA LANZA L SCUDELETTI M ROSSI E PUPPO F DAMASIO E INDIVERI F
Citation: G. Filaci et al., DSDNA-REACTIVE, NUCLEOHISTONE-REACTIVE AND DNASE-I-REACTIVE T-LYMPHOCYTES IN PATIENTS AFFECTED BY SYSTEMIC LUPUS-ERYTHEMATOSUS - CORRELATION WITH CLINICAL-DISEASE ACTIVITY, Clinical and experimental rheumatology, 14(5), 1996, pp. 543-550
HIGH EFFICACY OF FLUDARABINE-CONTAINING THERAPY (FLAG-FLANG) IN POOR-RISK ACUTE MYELOID-LEUKEMIA
Authors: CLAVIO M CARRARA P MIGLINO M PIERRI I CANEPA L BALLEARI E GATTI AM CERRI R CELESTI L VALLEBELLA E SESSAREGO M PATRONE F GHIO R DAMASIO E GOBBI M
Citation: M. Clavio et al., HIGH EFFICACY OF FLUDARABINE-CONTAINING THERAPY (FLAG-FLANG) IN POOR-RISK ACUTE MYELOID-LEUKEMIA, Haematologica, 81(6), 1996, pp. 513-520
MULTIPLE-MYELOMA IN THE ELDERLY - CLINICAL-FEATURES AND RESPONSE TO TREATMENT IN 113 PATIENTS
Authors: CLAVIO M CASCIARO S GATTI AM SPRIANO M BONANNI F POGGI A VALLEBELLA E PIETRASANTA D PRENCIPE E GORETTI R VIMERCATI R ROSSI E MASOUDI B GHIO R BOCCACCIO P RICCIARI S DAMASIO E GOBBI M
Citation: M. Clavio et al., MULTIPLE-MYELOMA IN THE ELDERLY - CLINICAL-FEATURES AND RESPONSE TO TREATMENT IN 113 PATIENTS, Haematologica, 81(3), 1996, pp. 238-244
FLUDARABINE, ARA-C, G-CSF WITH OR WITHOUT MITOXANTRONE (FLANG-FLAG) ARE TOLERABLE AND EFFECTIVE IN BAD PROGNOSIS ACUTE MYELOID-LEUKEMIA PATIENTS
Authors: GOBBI M CLAVIO M MIGLINO M CARRARA P BALLEARI E CERRI R PIERRI I CANEPA L CELESTI L VALLEBELLA E CAVALIERE M PIETRASANTA D GENNARO M GHIO R DAMASIO E
Citation: M. Gobbi et al., FLUDARABINE, ARA-C, G-CSF WITH OR WITHOUT MITOXANTRONE (FLANG-FLAG) ARE TOLERABLE AND EFFECTIVE IN BAD PROGNOSIS ACUTE MYELOID-LEUKEMIA PATIENTS, Experimental hematology, 24(9), 1996, pp. 585-585
PROGNOSTIC FACTORS OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML) ALLOGRAFTED IN FIRST COMPLETE REMISSION - AN ANALYSIS OF THE EORTC-GIMEMA AML 8A TRIAL
Authors: KEATING S SUCIU S DEWITTE T MANDELLI F WILLEMZE R RESEGOTTI L BROCCIA G THALER J LABAR B DAMASIO E BIZZI B ROTOLI B VEKHOFF A MUUS P PETTI MC DARDENNE M SOLBU G VEGNA ML ZITTOUN R
Citation: S. Keating et al., PROGNOSTIC FACTORS OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML) ALLOGRAFTED IN FIRST COMPLETE REMISSION - AN ANALYSIS OF THE EORTC-GIMEMA AML 8A TRIAL, Bone marrow transplantation, 17(6), 1996, pp. 993-1001
SHORT, INTENSIVE FLUDARABINE CONTAINING INDUCTION THERAPY (FLAG-FLANG) IN BAD PROGNOSIS ACUTE MYELOID-LEUKEMIA
Authors: GOBBI M CLAVIO M PIERRI I CANEPA L MIGLINO M CELESTI L CARRARA P GATTI AM VALLEBELLA E PIETRASANTA D CAVALIERE M DAMASIO E GHIO R
Citation: M. Gobbi et al., SHORT, INTENSIVE FLUDARABINE CONTAINING INDUCTION THERAPY (FLAG-FLANG) IN BAD PROGNOSIS ACUTE MYELOID-LEUKEMIA, Blood, 88(10), 1996, pp. 863-863
CLINICAL IMPLICATIONS OF CYTOKINE AND SOLUBLE RECEPTOR MEASUREMENTS IN PATIENTS WITH NEWLY-DIAGNOSED AGGRESSIVE NON-HODGKINS-LYMPHOMA
Authors: STASI R ZINZANI PL GALIENI P LAUTA VM DAMASIO E DISPENSA E DAMMACCO F VENDITTI A DELPOETA G CANTONETTI M PERROTTI A PAPA G TURA S
Citation: R. Stasi et al., CLINICAL IMPLICATIONS OF CYTOKINE AND SOLUBLE RECEPTOR MEASUREMENTS IN PATIENTS WITH NEWLY-DIAGNOSED AGGRESSIVE NON-HODGKINS-LYMPHOMA, European journal of haematology, 54(1), 1995, pp. 9-17
AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION COMPARED WITH INTENSIVE CHEMOTHERAPY IN ACUTE MYELOGENOUS LEUKEMIA
Authors: ZITTOUN RA MANDELLI F WILLEMZE R DEWITTE T LABAR B RESEGOTTI L LEONI F DAMASIO E VISANI G PAPA G CARONIA F HAYAT M STRYCKMANS P ROTOLI B LEONI P PEETERMANS ME DARDENNE M VEGNA ML PETTI MC SOLBU G SUCIU S
Citation: Ra. Zittoun et al., AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION COMPARED WITH INTENSIVE CHEMOTHERAPY IN ACUTE MYELOGENOUS LEUKEMIA, The New England journal of medicine, 332(4), 1995, pp. 217-223
TREATMENT OF HCL WITH 2-CHLORODEOXYADENOSINE (CDA) IN 2 DIFFERENT SCHEDULES
Authors: DAMASIO E
Citation: E. Damasio, TREATMENT OF HCL WITH 2-CHLORODEOXYADENOSINE (CDA) IN 2 DIFFERENT SCHEDULES, Blood, 86(10), 1995, pp. 3230-3230
LONG-TERM RESULTS OF INTERFERON TREATMENT IN HAIRY-CELL LEUKEMIA
Authors: CAPNIST G FEDERICO M CHISESI T RESEGOTTI L LAMPARELLI T FABRIS P ROSSI G INVERNIZZI R GUARNACCIA C LEONI P LAURIA F PAGNUCCO G FRASSOLDATI A DAMASIO E
Citation: G. Capnist et al., LONG-TERM RESULTS OF INTERFERON TREATMENT IN HAIRY-CELL LEUKEMIA, Leukemia & lymphoma, 14(5-6), 1994, pp. 457-464
MACOP-B VERSUS PROMACE-MOPP IN THE TREATMENT OF ADVANCED DIFFUSE NON-HODGKINS-LYMPHOMA - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL BY THE NON-HODGKINS-LYMPHOMA COOPERATIVE STUDY-GROUP
Authors: SERTOLI MR SANTINI G CHISESI T CONGIU AM RUBAGOTTI A CONTU A SALVAGNO L COSER P PORCELLINI A VESPIGNANI M CAPNIST G ROSSI E MANGONI L FABRIS P VINANTE O TEDESCHI L ENDRIZZI L MIGLIO LP PERROTTA A ROSSO R DAMASIO E RIZZOLI V
Citation: Mr. Sertoli et al., MACOP-B VERSUS PROMACE-MOPP IN THE TREATMENT OF ADVANCED DIFFUSE NON-HODGKINS-LYMPHOMA - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL BY THE NON-HODGKINS-LYMPHOMA COOPERATIVE STUDY-GROUP, Journal of clinical oncology, 12(7), 1994, pp. 1366-1374
FLUDARABINE THERAPY IN IMMUNOCYTOMA AND OTHER LOW-GRADE NON-HODGKINS-LYMPHOMAS
Authors: CLAVIO M CARRARA P SPRIANO M PIERRI I CANEPA L MIGLINO M CELESTI L ROSSI E GHIO R PATRONE F DAMASIO E GOBBI M
Citation: M. Clavio et al., FLUDARABINE THERAPY IN IMMUNOCYTOMA AND OTHER LOW-GRADE NON-HODGKINS-LYMPHOMAS, Journal of experimental & clinical cancer research, 13(3), 1994, pp. 257-263
FLUDARABINE THERAPY IN IMMUNOCYTOMA AND OTHER LOW-GRADE NON-HODGKINS-LYMPHOMAS
Authors: CLAVIO M CARRARA P SPRIANO M PIERRI I CANEPA L MIGLINO M CELESTI L ROSSI E GHIO R PATRONE F DAMASIO E GOBBI M
Citation: M. Clavio et al., FLUDARABINE THERAPY IN IMMUNOCYTOMA AND OTHER LOW-GRADE NON-HODGKINS-LYMPHOMAS, Journal of experimental & clinical cancer research, 13(3), 1994, pp. 257-263
Risultati: 1-25 | 26-33